Definitive Healthcare Corp.
Definitive Healthcare Corp. (DH) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
dh · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Definitive Healthcare Corp. (DH) measures how much investors pay for each dollar of the company's trailing earnings. DH's current PE ratio of N/A is calculated by dividing its stock price of $0.90 by its TTM earnings per share of -$1.63.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2019 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Healthcare Information Services · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Definitive Healthcare Corp.You DH | $95M | N/A | — | -$1.63 |
 Cabaletta Bio, Inc. CABA | $530M | N/A | — | -$1.64 |
 Editas Medicine, Inc. EDIT | $265M | N/A | — | -$1.80 |
 Kyverna Therapeutics, Inc. KYTX | $327M | N/A | — | -$3.64 |
 Nakamoto Inc. NAKA | $4.1B | N/A | — | -$4.60 |
 National Research Corporation NRC | $431M | 36.22x | — | $0.52 |
 Owens & Minor, Inc. OMI | $207M | N/A | — | -$14.24 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-1.30 | — | |
2024-12-31 FY2024 | — | $-3.54 | — | |
2023-12-31 FY2023 | — | $-1.79 | — | |
2022-12-31 FY2022 | — | $-0.07 | — | |
2021-12-31 FY2021 | — | $-0.53 | — | |
2020-12-31 FY2020 | — | $-0.54 | — | |
2019-12-31 FY2019 | — | $-0.24 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Definitive Healthcare Corp. (DH) measures how much investors pay for each dollar of the company's trailing earnings. DH's current PE ratio of N/A is calculated by dividing its stock price of $0.90 by its TTM earnings per share of -$1.63.
Frequently asked questions
DH pe ratio · 6 questionsDH's current PE ratio is N/A as of 2026-06-08, based on a stock price of $0.90 and TTM EPS of -$1.63. Data sourced from Financial Modeling Prep via DH's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Definitive Healthcare Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08